Council on Competitiveness and FDA plans to alter the drug approval process at FDA

Name: Council on Competitiveness and FDA plans to alter the drug approval process at FDA
Author: United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee. · 1993

Cover of Council on Competitiveness and FDA plans to alter the drug approval process at FDA

No description available.

Council on Competitiveness (U.S.)Drug ApprovalDrugsPharmaceutical policyTestingUnited StatesUnited States. Food and Drug Administration